Skip to main content

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Molecular Probes and Imaging Agents

Ribbon Icon
Tatjana Atanasijevic
Program Director
Division of Applied Science & Technology (Biomedical Imaging) Program Area: Molecular Probes and Imaging Agents
This program supports development and biomedical application of molecular probes and imaging agents across all imaging modalities for the visualization, characterization and quantification of normal biological and pathophysiological processes and anatomy in living organisms at the molecular, cellular and organ levels.

Emphasis

The emphasis is on engineering of targeting and responsive molecular probes of high sensitivity and specificity for PET and SPECT (radiotracers), MR (T1, T2, CEST, hyperpolarized agents), EPR, CT, optical (fluorescent and bioluminescent probes), ultrasound (microbubbles) and photoacoustic imaging.  The imaging agents may be based on nano- and micro-particles, liposomes, dendrimers, proteins, small organic and inorganic molecules etc., and detectable by one or more imaging modalities.  Imaging agent development through methodologies such as chemical synthesis, biological mutagenesis, microfabrication, etc., may be pursued with an intent of leading to in vivo biomedical application.

Outcome

The goal of this program is to generate robust molecular probes, imaging agents and platforms for biomedical application across all disease areas to facilitate diagnostics and improve understanding of disease state, progression, and therapeutic response.

Additional emphasis

This program also supports the development of other imaging agents, for example:

  • multimodal molecular probes (PET/MRI, PET/fluorescent, etc.)
  • imaging reporter genes and reporter gene/imaging probe duos
  • molecular probes as part of theranostic systems or biosensors
  • imaging agents for cell labelling and in vivo tracking
  • molecular probes for image-guided interventions

Note

The following related scientific areas are supported by other NIBIB programs:

Related News

NIBIB in the News
March 28, 2025

Brain cancer is the second most common cancer in children after leukemia, and it is also the deadliest, due to the fact that brain tumors are diverse, resistant to treatments and often hard to access surgically. A collaborative team of researchers at several institutions have developed a new way to profile brain cancers in children, paving the way for improved diagnostics and treatments. Source: UTSA Today

Science Highlights
March 26, 2025

College athletes want to know when they can return to playing sports after a concussion. NIH-funded researchers have developed a new prognostic model.

Science Highlights
March 21, 2025

Many cancer drugs fail to penetrate deep into tumors, but new research suggests magnetism could help pull them through.

NIBIB in the News
March 13, 2025

The National Institutes of Health (NIH) has selected four finalists with innovative, non-invasive technologies that seek to improve diagnosis of endometriosis.

Science Highlights
February 26, 2025

In a preclinical study, NIBIB researchers found that bone marrow transplants to treat sickle cell disease early in life may lower risk of stroke into adulthood.